FDA

A Close Concurrence on Certolizumab (Cimzia®)

By: Sang Hyo Kim, Staff Editor - This year, on July 23rd, FDA advisers voted 7 to 6, with one…

13 years ago

New Findings Regarding Cardiovascular Adverse Events with ADHD Medications

By: Aleena Cherian, Co-Copy Editor [Graphics-Focused] - Attention deficit/hyperactivity disorder (ADHD) is a chronic neurological behavior characterized by persistent patterns…

13 years ago

DIA 2013 Annual Meeting: Boston, Massachusetts

By: Kristin M. Cheng, PharmD candidate c/o 2014  -       The Drug Information Association (DIA) 2013 Annual Meeting took place…

13 years ago

Solving the HCV Enigma: Current and Future Drug Therapy for Hepatitis C

By: Tamara Yunusova, Senior Staff Editor - Approximately 3.2 million Americans have chronic hepatitis C infection.1 While acute cases are…

13 years ago

Compounding at a Crossroads: New Boundaries in the Aftermath of Tragedy?

Davidta Brown, PharmD Candidate c/o 2017 -      The debate on the nature of compounding practice and the extent to…

13 years ago

FDA Takes Major Strides Towards Opioid Abuse Prevention

By: Ada Seldin PharmD Candidate c/o 2015 - On April 16th, 2013, the FDA approved the labeling change for the…

13 years ago

Helping Solve the Cruel Mystery

By: Erica Dimitropoulos, Senior Staff Editor - Lupus is highly unpredictable and occurs without warning; there is no known cause…

13 years ago

Pay to Delay: The Honest Truth

By: David Ong, Pharm.D. Candidate c/o 2014 - Our current healthcare system receives much criticism from the press as well…

13 years ago

FDA Approves Dimethyl Fumarate for Treatment of Relapsing Forms of Multiple Sclerosis

By: Andy Zhang, PharmD Candidate c/o 2015 - On March 28, 2013, the U.S. Food and Drug Administration announced the…

13 years ago

Noninvasive Cancer Screening—Will We Ever Get It Right?

By: Frances Sousonis, Candidate c/o 2017 - Unfortunately, cancer is a disease about which many are able to share stories.…

13 years ago

Regulation of Low to Moderate Risk Medical Devices by the Food and Drug Administration

By: Hayeon Na, Co-Copy Editor [Content-Focused] - On March 22, 2013, Public Broadcasting Service (PBS) aired an episode of “Need…

13 years ago

Can a Pharmacist Prevent the Next Pileup?

By: Moisey Rafailov, PharmD Candidate c/o 2015 - It was early in the morning on New York’s Route 684 when…

13 years ago

Plan B® Pill Now Available Without Prescription to Women 15 Years of Age and Older

By: Bansri Patel - As of May 1st 2013, Plan B®, the brand name emergency contraception pill will now be…

13 years ago

FDA Approves New Drug ‘Tofacitinib’ for Rheumatoid Arthritis

By: Erica Dimitropoulos, Senior Staff Editor - Rheumatoid arthritis is a painful and often debilitating autoimmune disease characterized by symmetric…

13 years ago

Flu Season 2012-2013: Rising Opportunities for Pharmacists

By: Fawad Piracha, Pharm. D Candidate c/o 2016 - The 2012-2013 influenza season has developed into one of the greatest…

13 years ago

New P2Y12 Antagonist on the Rise

By Nancy Rizkalla, PharmD candidate c/o 2015 -        Percutaneous coronary intervention (PCI) with subsequent stent implantation is a highly…

13 years ago

U.S. v Caronia: Misdemeanor or Constitutional Right?

By: Tamara Yunusova, Staff Editor - On December 3, 2012, the U.S. Second Circuit Court of Appeals became the first…

13 years ago

New FDA Approval: Fycompa® to Treat Seizures

By: Bhavini Shah, PharmD Candidate c/o 2013  - Fycompa® (perampanel) has received the U.S. Food and Drug Administration (FDA) approval…

13 years ago

FDA Approves New Indication for Botox (OnabotulinumtoxinA) for Urinary Incontinence

By: Bethsy Jacob, PharmD Candidate 2014 - On January 18, 2013, the U.S. Food and Drug Administration (FDA) announced a…

13 years ago

Rho Chi Beta Delta Chapter Induction Ceremony

By:  Bethsy Jacob, PharmD Candidate c/o 2013 - On January 24, 2013, Rho Chi Beta Delta Chapter successfully conducted its…

13 years ago

Emerging Pathways For Treating Hepatitis C Virus

By:  Maria Sorbera, PharmD Candidate c/o 2013, AMSCOP, LIU - Hepatitis C is the leading cause of chronic liver disease…

13 years ago

Varizig® for Chickenpox Symptoms

By: Steve Soman, Co-Editor-in-Chief - Varicella Zoster Immune Globulin (Varizig®) was approved by the FDA on December 21st of 2012.…

13 years ago

The Opioid Debate: PROP and PROMPT Battle Away

By: Tamara Yunusova - On Wednesday, July 25th a petition signed by the reform group Physicians for Responsible Opioid Prescribing…

13 years ago

New Healthcare Law Concerning Birth Control Causes Debate

By: Katie Cimmino, Pharm D. Candidate c/o 2015 -  With the start of the New Year the French government is…

13 years ago

FDA Approves Apixaban For Nonvalvular Atrial Fibrillation

By: Alexandra Alleva, PharmD candidate c/o 2013 - As of December 28th, Bristol-Myers Squibb and Pfizer's brand name oral anticoagulant,…

13 years ago

Tackling America’s Drug Shortage Crisis

By: John S Lim, PharmD Candidate c/o 2013 - America’s focus on healthcare, as well as its position as one…

14 years ago

Adverse Events from Ingestion of OTC Eye Drops and Nasal Sprays

By Tasnima Nabi, PharmD Candidate c/o 2016 - The FDA has issued warnings on accidental ingestion of over-the-counter eye drops…

14 years ago

Fungal Meningitis Outbreak: A Sobering Tragedy

By: Mahdieh Danesh Yazdi, Associate Student Editor - For the past few weeks, we have heard about the terrible breakout…

14 years ago

New Drug Review: Tofacitinib (Xeljanz®)

By: Jessica Lee, PharmD Candidate c/o 2013 - Rheumatoid arthritis (RA) is an autoimmune disease in which the immune system…

14 years ago

A New Frontier in Health Care: Digital Medicine

By: Mahdieh Danesh Yazdi - We live in amazing times. Technology does not progress by steps anymore, it grows by…

14 years ago

Influenza Vaccines: Projected Strains for the 2012—2013 Season

By: Joo Hee Kwon, Pharm.D. Candidate c/o 2013 - There are 3 antigenic types of influenza: A, B, and C.…

14 years ago

Bisphosphonates and Atypical Fracture Risk

By: Steve Soman, Pharm.D. Candidate c/o 2013 - Bisphosphonates are proven to enhance bone density and reduce fracture incidence in…

14 years ago

Brand Vs. Generic: What Every Prescriber Should Know

By: Marina Yermolayeva, PharmD Candidate c/o 2013 - “I’m allergic to the generic; I need the brand name medication,” is…

14 years ago

Meet the new Beta 3 Agonist: Mirabegron (Myrbetriq®)

By: Steve P. Soman - Mirabegron (Mybetriq®), known also by the brand name Betanis®in Japan, is a new once daily…

14 years ago

DIA 2012: St. John’s Students Collaborate to Innovate in Philadelphia

By: Michael Cronin, Pharm.D.  Candidate c/o 2014 - The Drug Information Association (DIA) student chapter at St. John's University College…

14 years ago

The Pathophysiology of Syndeham’s Chorea

By: Neal Shah, Co Editor-In-Chief - Dyskinesias are abnormal, involuntary movement disorders.  Subsets of dyskinesias include choreas and atheosis.  Chorea…

14 years ago

The Pathology of Pure Red Cell Aplasia

By: Neal Shah, Co Editor-In-Chief - Pure Red Cell Aplasia (PRCA), also known as erythroblastopenia, is characterized by a suppression…

14 years ago

The Challenges of Pediatric Clinical Drug Trials and Drug Product Labeling

By: Shannon Tellier, Associate Student Editor - The disease burden in children outweighs the number of pediatric clinical drug trials…

14 years ago

Effect of Intravenous Ondansetron on QT Interval Prolongation

By: Raymond Wu, Pharm.D. Candidate c/o 2013   The 5-hydroxytryptamine type 3 (5HT3) antagonists (e.g. ondansetron [Zofran®]) are commonly used…

14 years ago

Risk versus Benefit: Prescription to Over the Counter Medications

By: Maria A. Sorbera, Pharm.D. Candidate c/o 2013 -   Maria Sorbera was the 2011-2012 President of the Rho Chi…

14 years ago

Proton Pump Inhibitor Use and Complications

By: Lauren Kaveski, Pharm.D. Candidate c/o 2013 - We see proton pump inhibitors (PPIs) used in many medication regimens, but…

14 years ago

Rho Chi Post Interview with Dean Mangione

By: Mohamed Dungersi & Mahdieh Danesh Yazdi, Associate Student Editors - Each month, the editors at the Rho Chi Post…

14 years ago

Student Pharmacist Star of the Month: Michelle Pernice

By: Marie Huang - Each month, the Rho Chi Post has the wonderful opportunity to sit down with an inspiring…

14 years ago

Sativex®: A Realistic Option for Advanced Cancer Pain?

By: Kathlynn Ferrer, Pharm.D. Candidate c/o 2013 - Nabiximols (Sativex®) is a buccal spray that has been approved for use…

14 years ago

Korlym® For Endogenous Cushing’s Syndrome

By: Alexandra Alleva, Pharm.D. Candidate c/o 2013 - On February 17, 2012, the US Food and Drug Administration (FDA) approved…

14 years ago

APhA Annuals 2012 in New Orleans

By: Nandini Puranprashad - This year we had an awesome turnout of 17 attendees representing the American Pharmacist Association Academy…

14 years ago

HMG-CoA Reductase Inhibitors And Memory Loss

By: Yufan (Frank) Liu, Pharm.D. Candidate c/o 2013 - Results of numerous epidemiological studies have indicated that having high serum…

14 years ago

Counterfeit Prescription Medications: A Global Threat

By: Lunbao (Jerry) Huang, Pharm.D. Candidate c/o 2013 - Counterfeit prescription medications are becoming a great concern for us. They…

14 years ago

Drug Shortage Update: FDA Successfully Alleviates Chemotherapy Shortage

By: Mahdieh Danesh Yazdi - As previously reported, there is currently great concern in the medical community because of the…

14 years ago

Jentadueto Approved by FDA for Type 2 Diabetes Mellitus

By: Ebey P. Soman - The FDA recently approved a combination tablet of linagliptin with metformin hydrochloride (Jentadueto®) for the…

14 years ago